Abstract:Abstract Motivation Traditional drug discovery and development are often time-consuming and high risk. Repurposing/repositioning of approved drugs offers a relatively low-cost and high-efficiency approach toward rapid development of efficacious treatments. The emergence of large-scale, heterogeneous biological networks has offered unprecedented opportunities for developing in silico drug repositioning approaches. However, capturing highly non-linear, heterogeneous network structures by most existing approaches for drug repositioning has been challenging. Results In this study, we developed a network-based deep-learning approach, termed deepDR, for in silico drug repurposing by integrating 10 networks: one drug–disease, one drug-side-effect, one drug–target and seven drug–drug networks. Specifically, deepDR learns high-level features of drugs from the heterogeneous networks by a multi-modal deep autoencoder. Then the learned low-dimensional representation of drugs together with clinically reported drug–disease pairs are encoded and decoded collectively via a variational autoencoder to infer candidates for approved drugs for which they were not originally approved. We found that deepDR revealed high performance [the area under receiver operating characteristic curve (AUROC) = 0.908], outperforming conventional network-based or machine learning-based approaches. Importantly, deepDR-predicted drug–disease associations were validated by the ClinicalTrials.gov database (AUROC = 0.826) and we showcased several novel deepDR-predicted approved drugs for Alzheimer’s disease (e.g. risperidone and aripiprazole) and Parkinson’s disease (e.g. methylphenidate and pergolide). Availability and implementation Source code and data can be downloaded from https://github.com/ChengF-Lab/deepDR Supplementary information Supplementary data are available online at Bioinformatics.

Deep learning in target prediction and drug repositioning: Recent advances and challenges

Machine Learning and Deep Learning Strategies in Drug Repositioning

Machine learning for drug repositioning: Recent advances and challenges

Deep-Learning-Based Drug-Target Interaction Prediction.

Recent Progress of Deep Learning in Drug Discovery

deepDR: a network-based deep learning approach to in silico drug repositioning

Prediction of Drug-Target Binding Affinity Based on Deep Learning Models

Implementation of Deep Learning in Drug Design

Deep Learning in Drug Discovery: Current Landscape and Future Prospects

A compact review of progress and prospects of deep learning in drug discovery

The rise of deep learning in drug discovery

Correction To: Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era

Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network

Network-Based Approaches for Drug Repositioning.

Predicting Drug-Target Interaction Via Wide And Deep Learning

DeepDrug: A General Graph-Based Deep Learning Framework for Drug-Drug Interactions and Drug-Target Interactions Prediction

Deep Learning in Drug Design—Progress, Methods, and Challenges

A comprehensive review of the recent advances on predicting drug-target affinity based on deep learning

Deep learning for drug‐drug interaction prediction: A comprehensive review

A geometric deep learning framework for drug repositioning over heterogeneous information networks

Research and Implementation of Drug Relocation Algorithm Based on Deep Learning